Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension

Launched by CHINESE PULMONARY VASCULAR DISEASE RESEARCH GROUP · Oct 22, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how obstructive sleep apnea (OSA) affects patients with pulmonary hypertension, a condition where the blood pressure in the lungs is too high. Researchers want to find out how common OSA is among these patients and how it might influence their overall health and survival. To do this, adults who have been diagnosed with pulmonary hypertension will be asked to participate. Eligible participants are those aged 18 and older, but not pregnant or with certain other conditions like central sleep apnea.

Participants will undergo a sleep study while they are still in the hospital, using a portable device to monitor their breathing patterns and oxygen levels during sleep. Based on the results, they will be divided into two groups: those with OSA and those without. The study will track their health over time, focusing on any worsening of their condition, such as decreased ability to exercise or hospitalizations. This research could help improve understanding of how sleep apnea impacts people with pulmonary hypertension, which is important for managing their care effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥18 years old
• • Diagnosed with pulmonary hypertension by right heart catheterization
• Exclusion Criteria:
• • Pregnancy
• • Central sleep apnea
• • Previous treatment for sleep-disordered breathing
• • Unavailable or incomplete sleep data
• • Requiring nocturnal oxygen supplementation